US Health Reform Won’t Benefit Richter

  • 24 Mar 2010 12:00 AM
US Health Reform Won’t Benefit Richter
"Drug manufacturer Richter will not be a beneficiary of the US health reform signed into law yesterday, spokeswoman Zsuzsa Beke said.

Richter mostly exports oral contraceptives to the US, but these are sold over the counter, not on prescription.

The growing sentiment against abortion in the US could indirectly favour Richter in the longer term, by boosting the sale of its Plan B contraceptives, Beke remarked."

Source: Hungary Around the Clock.

This news item is one of many published daily by HATC, a premier subscription news service which distributes English-language info about Hungary via email or fax. For a free trial of HATC follow this link and click on 'Free Trial Subscription'.

  • How does this content make you feel?